FDA approves Clinical Data’s Viibryd for major depressive disorder

FDA approves Clinical Data’s Viibryd for major depressive disorder
Clinical Data, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved vilazodone HCl tablets, to be marketed under the brand name Viibryd™, for the treatment of adults with major depressive disorder (MDD).
Read more on News-Medical-Net

No death penalty for killer
Jury cites Allentown man’s horrendous upbringing, low IQ in voting for life in prison. An Allentown killer who remained stoic throughout his murder trial last week broke down during the penalty phase Monday when his mother tearfully apologized for abusing him as a child and raising him in feces-filled homes that sometimes lacked heat, electricity and food.
Read more on The Morning Call